Gainers

• Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday's regular session. The market value of their outstanding shares is at $2.0 million.
• SL Science Holding (NASDAQ:SLBT) stock rose 27.89% to $3.38. The market value of their outstanding shares is at $1.4 billion.
• Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock rose 27.65% to $0.12.
• Autolus Therapeutics (NASDAQ:AUTL) shares moved upwards by 25.16% to $1.86. The company's market cap stands at $396.5 million.
• Beyond Air (NASDAQ:XAIR) stock rose 23.79% to $6.53. The market value of their outstanding shares is at $3.8 million.
• Camp4 Therapeutics (NASDAQ:CAMP) stock moved upwards by 21.73% to $4.2. The company's market cap stands at $179.1 million.

Losers

• CalciMedica (NASDAQ:CALC) shares declined by 21.4% to $0.79 during Monday's regular session. The market value of their outstanding shares is at $15.7 million.
• NewGenIvf Group (NASDAQ:NIVF) stock decreased by 17.71% to $0.67. The market value of their outstanding shares is at $2.7 million.
• Genprex (NASDAQ:GNPX) shares declined by 16.53% to $5.0. The market value of their outstanding shares is at $3.0 million.
• Fortress Biotech (NASDAQ:FBIO) stock decreased by 15.34% to $2.65. The market value of their outstanding shares is at $103.9 million.
• Moleculin Biotech (NASDAQ:MBRX) shares decreased by 13.91% to $0.34. The market value of their outstanding shares is at $2.1 million.
• Shuttle Pharmaceuticals (NASDAQ:SHPH) stock declined by 12.9% to $3.31. The market value of their outstanding shares is at $2.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.